| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 4 | +50.00% | -0.63% | +1.71% | -2.34% | -1.40% | — |
| 14d | 4 | +50.00% | +2.55% | +2.22% | +0.34% | +2.67% | — |
| 30d | 4 | +0.00% | +28.26% | +1.99% | +26.27% | +28.13% | — |
| 60d | 4 | +0.00% | +14.29% | +3.75% | +10.55% | +8.92% | — |
| 90d | 4 | +25.00% | +15.29% | +7.21% | +8.08% | +8.47% | — |
| 180d | 4 | +0.00% | +53.87% | +8.69% | +45.18% | +46.86% | — |
| 1y | 4(1 pending) | +0.00% | +86.02% | +13.77% | +72.24% | +102.80% | — |
| 2y | 4(2 pending) | +0.00% | +53.70% | +32.66% | +21.05% | +21.05% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ALDX ALDEYRA THERAPEUTICS, INC. | SALE Chief Development Officer | 22,073 | $5.15 | $113.7K | 221,799 | Aug 11, 2025 | Aug 13, 2025 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 202,427 | — | — | 202,427 | Mar 4, 2025 | Mar 6, 2025 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | SALE Chief Development Officer | 16,041 | $4.74 | $76.0K | 236,771 | Aug 12, 2024 | Aug 14, 2024 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | SALE Chief Development Officer | 11,537 | $3.16 | $36.5K | 252,812 | Mar 12, 2024 | Apr 17, 2024 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | SALE Chief Development Officer | 11,537 | $3.16 | $36.5K | 243,495 | Mar 12, 2024 | Mar 12, 2024 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | SALE Chief Development Officer | 18,231 | $3.41 | $62.1K | 255,032 | Mar 11, 2024 | Mar 12, 2024 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 405,450 | — | — | 405,450 | Mar 9, 2024 | Mar 12, 2024 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 220,258 | — | — | 220,258 | Feb 28, 2023 | Mar 2, 2023 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 185,605 | — | — | 273,263 | Jul 15, 2022 | Jul 19, 2022 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 69,473 | — | — | 69,473 | Jul 15, 2022 | Jul 19, 2022 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 250,000 | — | — | 250,000 | Mar 30, 2022 | Apr 1, 2022 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 64,395 | — | — | 87,658 | Mar 30, 2022 | Apr 1, 2022 ↗ | View → |
| ALDX ALDEYRA THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 116,201 | — | — | 116,201 | Apr 12, 2021 | Apr 14, 2021 ↗ | View → |